2 research outputs found

    Early Identification of Hospitalized Patients Lacking Prescription Drug Insurance

    Get PDF
    Background According to 2021 data from the US Department of Health and Human Services, 16% of persons in the United States under the age of 65 do not have prescription drug insurance.1Unsurprisingly, prior investigations have shown that the presence of prescription drug insurance is associated with reduced probability of hospital admission and length of stay for many common medical conditions.2A large majority of hospitalized patients are started on at least one new medication at the time of hospital discharge. Increasing the proportion of individuals with prescription drug insurance would have a substantial benefit on our population\u27s health. One care gap we seek to address is the timely identification of hospitalized patients who do not have prescription drug insurance well before hospital discharge. Within our health system, it is often the case that individuals lacking prescription drug insurance are not appropriately identified until the time of hospital discharge. This can have several consequences, including inadequate access to life-saving medications following hospital discharge, prolonged length of stay as these issues are addressed, or direct costs to the health system in the form of charity care that is pursued to facilitate timely discharge. This initiative\u27s purpose would be to screen patients for prescription drug insurance at the time of hospital admission to allow for ample time to plan for ongoing access to medications following hospital discharge

    Pharmacist-Assisted Insulin Titration in Primary Care to Improve Diabetes Outcomes

    Get PDF
    Background Problem Statement: Approximately, 90% of patients with Type 2 Diabetes (T2DM) are treated by primary care providers (PCPs) and with a growing aging population, and a shrinking primary care workforce, the demand for PCPs to provide care to diabetics is only expected to further worsen. Despite novel therapies in T2DM, insulin remains a mainstay in treatment. Titrating insulin is a tedious and time-consuming task, requiring frequent follow-ups and lengthy conversations, increasing the burden of care on PCPs. Project AIM: Assess efficacy of pharmacy–assisted insulin titration in T2DM in achieving glycemic control by monitoring blood glucose and A1c changes Evaluate PCP satisfaction with this team-based approac
    corecore